187 related articles for article (PubMed ID: 30203754)
1. Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia.
Wang J; Yang C
Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1649-1652. PubMed ID: 30203754
[TBL] [Abstract][Full Text] [Related]
2. Effects of a combination of erythromycin sequential therapy and azithromycin on lung function and inflammatory factors in children with severe mycoplasma pneumonia.
Wang F; Nan K; Hao L; Li H; Wang C; Zhang L; Jiang L; Tian Y
Pak J Pharm Sci; 2021 Nov; 34(6(Special)):2447-2454. PubMed ID: 35039258
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of Saccharomyces boulardii powder combined with azithromycin sequential therapy in treatment of children with diarrhea secondary to Mycoplasma pneumoniae pneumonia].
Chen QF; Zhang YW
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Feb; 20(2):116-120. PubMed ID: 29429459
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
Shan LS; Liu X; Kang XY; Wang F; Han XH; Shang YX
World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
[TBL] [Abstract][Full Text] [Related]
6. Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience.
Lu YJ; Chen TH; Lin LH; Shen CM; Huang CH
J Microbiol Immunol Infect; 2008 Aug; 41(4):307-10. PubMed ID: 18787737
[TBL] [Abstract][Full Text] [Related]
7. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children: A protocol of randomized controlled trial.
Wang M; Li H; Yang J; Wang M; Liu J
Medicine (Baltimore); 2021 Mar; 100(12):e25135. PubMed ID: 33761679
[TBL] [Abstract][Full Text] [Related]
9. Application value of erythromycin combined with azithromycin sequential therapy in the treatment of mycoplasma pneumonia in children.
Li J; Tang W; Wang W
Minerva Pediatr (Torino); 2022 Apr; 74(2):247-249. PubMed ID: 34264050
[No Abstract] [Full Text] [Related]
10. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
11. [Continuous versus intermittent azithromycin administration for treatment of Mycoplasma pneumonia-induced pneumonia: effects and drug resistance in rats].
Wei W
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1918-9, 1922. PubMed ID: 20813702
[TBL] [Abstract][Full Text] [Related]
12. Effect of Qingfei Mixture () on pediatric mycoplasma pneumoniae pneumonia with phlegm heat obstructing Fei (Lung) syndrome.
Yang AJ; Xi K; Yao YQ; Ding YX; Yang LJ; Cui H
Chin J Integr Med; 2017 Sep; 23(9):681-688. PubMed ID: 28861888
[TBL] [Abstract][Full Text] [Related]
13. Effect of Qingfei Huatan Huoxue Decoction combined with azithromycin on pulmonary function and inflammatory factors in children with Mycoplasma pneumonia.
Yin M
Pak J Pharm Sci; 2021 Nov; 34(6(Supplementary)):2317-2323. PubMed ID: 35039269
[TBL] [Abstract][Full Text] [Related]
14. The timing of azithromycin treatment is not associated with the clinical prognosis of childhood Mycoplasma pneumoniae pneumonia in high macrolide-resistant prevalence settings.
Yang D; Chen L; Chen Z
PLoS One; 2018; 13(1):e0191951. PubMed ID: 29377957
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods.
Chen Y; Zhang Y; Tang QN; Shi HB
Ital J Pediatr; 2024 Mar; 50(1):38. PubMed ID: 38439015
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of azithromycin combined with glucocorticoid on refractory Mycoplasma pneumoniae pneumonia in children: A PRISMA-compliant systematic review and meta-analysis.
Qiu JL; Huang L; Shao MY; Chai YN; Zhang HJ; Li XF; Sun XX; Zhao QY; Duan F; Zhai WS
Medicine (Baltimore); 2020 May; 99(22):e20121. PubMed ID: 32481378
[TBL] [Abstract][Full Text] [Related]
17. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
[TBL] [Abstract][Full Text] [Related]
18. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
Ríos AM; Fonseca-Aten M; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Ramilo O; Hardy RD
Antimicrob Agents Chemother; 2005 Sep; 49(9):3970-3. PubMed ID: 16127085
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.
Yuan C; Min FM; Ling YJ; Li G; Ye HZ; Pan JH; Wang L; Xie YP
Comb Chem High Throughput Screen; 2018; 21(10):749-754. PubMed ID: 30636596
[TBL] [Abstract][Full Text] [Related]
20. Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections.
Esposito S; Bosis S; Faelli N; Begliatti E; Droghetti R; Tremolati E; Porta A; Blasi F; Principi N
Pediatr Infect Dis J; 2005 May; 24(5):438-44. PubMed ID: 15876944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
